中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 38 Issue 7
Jul.  2022
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2022  >  38(7): 1595-1601

Influence of fatty liver on the severity of acute pancreatitis

DOI: 10.3969/j.issn.1001-5256.2022.07.025

  • Department of Medical Imaging, The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, Baotou, Inner Mongolia Autonomous Region 014010, China

Research funding:

Seeding Project of Baotou Medical College (BYJJ-QM-201753)

More Information
  • Corresponding author: CHEN Qiang, xy198033@sina.com (ORCID: 0000-0002-0864-4287)
  • Received Date: 2021-11-26
  • Accepted Date: 2022-02-14
  • Published Date: 2022-07-20
    Abstract
  •   Objective  To investigate the influence of fatty liver on the severity of acute pancreatitis (AP) by comparing clinical and imaging data between AP patients with fatty liver and those without fatty liver.  Methods  Clinical data were collected from 328 AP patients who were admitted to The First Affiliated Hospital of Baotou Medical College, Inner Mongolia University of Science and Technology, from December 2017 to May 2020, and according to the presence or absence of fatty liver, they were divided into fatty liver+AP group (FLAP group) and non-fatty liver AP group (NFLAP group). The two groups were compared in terms of the indices such as general information, laboratory markers, and chronic diseases. The chi-square test was used to compare the rates of binary variables, and the t-test or the Mann-Whitney U test was used for comparison of continuous variables. The Pearson liner correlation analysis was used to investigate the correlation between continuous variables, and the Spearman rank correlation analysis was used to investigate the correlation between rank variables. The multivariate logistic regression analysis and the chi-square test were used to investigate the influencing factors and possible risk predictive factors for moderate-severe AP (MSAP) and severe AP (SAP).  Results  Among the 328 AP patients enrolled, there were 133(40.55%) in the FLAP group and 195(59.45%) in the NFLAP group. Hyperlipidemia (42.1%) was the main cause of AP, followed by gallstone disease (39.3%). Compared with the NFLAP group, the FLAP group had a significantly lower mean age (41.32±11.43 years vs 54.83±15.21 years, t=8.704, P < 0.001) and significantly higher proportion of male patients (78.95% vs 55.38%, χ2=19.281, P < 0.001), proportion of patients with chronic disease (70.68% vs 45.64%, χ2=20.094, P < 0.001), and incidence rate of MSAP+SAP (59.40% vs 41.03%, χ2=10.686, P < 0.01). Compared with the NFLAP group, the FLAP group had significantly higher levels of triglyceride, total cholesterol, fasting blood glucose, and C-reactive protein on days 1 and 2 after admission (Z=-8.216, -5.637, -4.001, -3.053, and -3.325, all P < 0.05), as well as significantly lower levels of blood amylase, blood lipase, high-density lipoprotein, alanine aminotransferase, aspartate aminotransferase, and total bilirubin (Z=-5.401, -2.842, -3.594, -2.276, -2.643, and -2.339, all P < 0.05). Patients with a relatively young age (< 50 years) (odds ratio [OR]=1.84, 95% confidence interval [CI]: 1.18-2.89, P < 0.01) and a past history of hypertension (OR=3.58, 95%CI: 1.96-6.54, P < 0.001) or hyperlipidemia (OR=3.36, 95%CI: 1.03-10.94, P < 0.05) had a relatively high risk of MSAP+SAP. The FLAP group had a significantly higher risk of MSAP+SAP than the NFLAP group (OR=2.10, 95%CI: 1.34-3.29, P < 0.01).  Conclusion  FLAP patients often have a relatively young age of onset, hyperlipidemia, and a relatively high proportion of patients with MSAP+SAP. Fatty liver is not only an influencing factor for MSAP+SAP, but also an important predictive factor for the risk of MSAP+SAP.

     

    • FullText(HTML)
  • loading
    • References(34)
  • [1]
    LANKISCH PG, APTE M, BANKS PA. Acute pancreatitis[J]. Lancet, 2015, 386(9988): 85-96. DOI: 10.1016/S0140-6736(14)60649-8.
    [2]
    CALUIANU EI, ALEXANDRU DO, GEORGESCU M, et al. Utilizing multiparameter scores and procalcitonin as prognosis markers for the degree of severity of acute pancreatitis[J]. Curr Health Sci J, 2017, 43(4): 311-317. DOI: 10.12865/CHSJ.43.04.04.
    [3]
    WU BU, JOHANNES RS, SUN X, et al. The early prediction of mortality in acute pancreatitis: a large population-based study[J]. Gut, 2008, 57(12): 1698-1703. DOI: 10.1136/gut.2008.152702.
    [4]
    SHEN HN, LU CL, LI CY. Epidemiology of first-attack acute pancreatitis in Taiwan from 2000 through 2009: a nationwide population-based study[J]. Pancreas, 2012, 41(5): 696-702. DOI: 10.1097/MPA.0b013e31823db941.
    [5]
    BALTHAZAR EJ, ROBINSON DL, MEGIBOW AJ, et al. Acute pancreatitis: value of CT in establishing prognosis[J]. Radiology, 1990, 174(2): 331-336. DOI: 10.1148/radiology.174.2.2296641.
    [6]
    SZENTESI A, PÁRNICZKY A, VINCZE Á, et al. Multiple hits in acute pancreatitis: components of metabolic syndrome synergize each other's deteriorating effects[J]. Front Physiol, 2019, 10: 1202. DOI: 10.3389/fphys.2019.01202.
    [7]
    The Chinese National Workshop on Fatty Liver and Alcoholic Liver disease for the Chinese Liver Disease Association. Guidelines for management of nonalcoholic fatty liver disease: an updated and revised edition[J]. J Mod Med Health, 2011, 27(5): 641-644. DOI: 10.3760/cma.j.issn.1007-3418.2011.03.002.

    中华医学会肝病学分会脂肪肝和酒精性肝病学组. 非酒精性脂肪性肝病诊疗指南(2010年修订版)[J]. 现代医药卫生, 2011, 27(5): 641-644. DOI: 10.3760/cma.j.issn.1007-3418.2011.03.002.
    [8]
    Chinese Pancreatic Surgery Association, Chinese Society of Surgery, Chinese Medical Association. Guidelines for diagnosis and treatment of acute pancreatitis in China(2021)[J]. Chin J Dig Surg, 2021, 20(7): 730-739. DOI: 10.3760/cma.j.cn115610-20210622-00297.

    中华医学会外科学分会胰腺外科学组. 中国急性胰腺炎诊治指南(2021)[J]. 中华消化外科杂志, 2021, 20(7): 730-739. DOI: 10.3760/cma.j.cn115610-20210622-00297.
    [9]
    ZHU Y, PAN X, ZENG H, et al. A study on the etiology, severity, and mortality of 3260 patients with acute pancreatitis according to the revised atlanta classification in Jiangxi, China over an 8-year period[J]. Pancreas, 2017, 46(4): 504-509. DOI: 10.1097/MPA.0000000000000776.
    [10]
    YIN G, CANG X, YU G, et al. Different clinical presentations of hyperlipidemic acute pancreatitis: a retrospective study[J]. Pancreas, 2015, 44(7): 1105-1110. DOI: 10.1097/MPA.0000000000000403.
    [11]
    WU D, ZHANG M, XU S, et al. Nonalcoholic fatty liver disease aggravated the severity of acute pancreatitis in patients[J]. Biomed Res Int, 2019, 2019: 9583790. DOI: 10.1155/2019/9583790.
    [12]
    de PRETIS N, AMODIO A, FRULLONI L. Hypertriglyceridemic pancreatitis: Epidemiology, pathophysiology and clinical management[J]. United European Gastroenterol J, 2018, 6(5): 649-655. DOI: 10.1177/2050640618755002.
    [13]
    IDILMAN IS, KESKIN O, CELIK A, et al. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease[J]. Acta Radiol, 2016, 57(3): 271-278. DOI: 10.1177/0284185115580488.
    [14]
    YAN YF, JIANG X, ZHONG R, et al. Clinical features and prognosis of acute pancreatitis with nonalcoholic fatty liver disease[J]. J Clin Hepatol, 2020, 36(5): 1091-1096. DOI: 10.3969/j.issn.1001-5256.2020.05.028.

    严永峰, 蒋鑫, 钟瑞, 等. 急性胰腺炎合并非酒精性脂肪性肝病的临床特征及预后分析[J]. 临床肝胆病杂志, 2020, 36(5): 1091-1096. DOI: 10.3969/j.issn.1001-5256.2020.05.028.
    [15]
    CHARLESWORTH A, STEGER A, CROOK MA. Acute pancreatitis associated with severe hypertriglyceridaemia; A retrospective cohort study[J]. Int J Surg, 2015, 23(Pt A): 23-27. DOI: 10.1016/j.ijsu.2015.08.080.
    [16]
    MIKOLASEVIC I, MILIC S, ORLIC L, et al. Metabolic syndrome and acute pancreatitis[J]. Eur J Intern Med, 2016, 32: 79-83. DOI: 10.1016/j.ejim.2016.04.004.
    [17]
    HAO RR, WANG H, LUO J, et al. Analysis of risk factors related to nonalcoholic fatty liver disease in Chinese elderly[J]. J Clin Exp Med, 2020, 19(2): 156-158. DOI: 10.3969/j.issn.1671-4695.2020.02.012.

    郝瑞瑞, 王欢, 罗佳, 等. 老年非酒精性脂肪性肝病相关危险因素分析[J]. 临床和实验医学杂志, 2020, 19(2): 156-158. DOI: 10.3969/j.issn.1671-4695.2020.02.012.
    [18]
    XU C, QIAO Z, LU Y, et al. Influence of fatty liver on the severity and clinical outcome in acute pancreatitis[J]. PLoS One, 2015, 10(11): e0142278. DOI: 10.1371/journal.pone.0142278.
    [19]
    YOON SB, LEE IS, CHOI MH, et al. Impact of fatty liver on acute pancreatitis severity[J]. Gastroenterol Res Pract, 2017, 2017: 4532320. DOI: 10.1155/2017/4532320.
    [20]
    HUANG YX, JIA L, JIANG SM, et al. Incidence and clinical features of hyperlipidemic acute pancreatitis from Guangdong, China: a retrospective multicenter study[J]. Pancreas, 2014, 43(4): 548-552. DOI: 10.1097/MPA.0000000000000069.
    [21]
    YOUNOSSI ZM, GOLABI P, de AVILA L, et al. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis[J]. J Hepatol, 2019, 71(4): 793-801. DOI: 10.1016/j.jhep.2019.06.021.
    [22]
    DIETRICH P, HELLERBRAND C. Non-alcoholic fatty liver disease, obesity and the metabolic syndrome[J]. Best Pract Res Clin Gastroenterol, 2014, 28(4): 637-653. DOI: 10.1016/j.bpg.2014.07.008.
    [23]
    SINGH A, AMIN H, GARG R, et al. Increased prevalence of obesity and metabolic syndrome in patients with alcoholic fatty liver disease[J]. Dig Dis Sci, 2020, 65(11): 3341-3349. DOI: 10.1007/s10620-020-06056-1.
    [24]
    WANG YH, GAO Y. Research progress in diagnosis and treatment of non-alcoholic fatty liver disease combinated with type 2 diabetes mellitus[J]. J Jilin Univ(Med Edit), 2020, 46(6): 1324-1331. DOI: 10.13481/j.1671-587x.20200634.

    王雨涵, 高影. 非酒精性脂肪性肝病并发2型糖尿病诊断和治疗的研究进展[J]. 吉林大学学报(医学版), 2020, 46(6): 1324-1331. DOI: 10.13481/j.1671-587x.20200634.
    [25]
    MIKOLASEVIC I, ORLIC L, POROPAT G, et al. Nonalcoholic fatty liver and the severity of acute pancreatitis[J]. Eur J Intern Med, 2017, 38: 73-78. DOI: 10.1016/j.ejim.2016.10.019.
    [26]
    RATHNAKAR SK, VISHNU VH, MUNIYAPPA S, et al. Accuracy and predictability of PANC-3 scoring system over APACHE Ⅱ in acute pancreatitis: a prospective study[J]. J Clin Diagn Res, 2017, 11(2): PC10-PC13. DOI: 10.7860/JCDR/2017/23168.9375.
    [27]
    STAUBLI SM, OERTLI D, NEBIKER CA. Laboratory markers predicting severity of acute pancreatitis[J]. Crit Rev Clin Lab Sci, 2015, 52(6): 273-283. DOI: 10.3109/10408363.2015.1051659.
    [28]
    European Association for the Study of the Liver(EASL), European Association for the Study of Diabetes(EASD), European Association for the Study of Obesity(EASO). EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease[J]. Diabetologia, 2016, 59(6): 1121-1140. DOI: 10.1007/s00125-016-3902-y.
    [29]
    TANG QQ, SU SY, FANG MY. Zinc supplement modulates oxidative stress and antioxidant values in rats with severe acute pancreatitis[J]. Biol Trace Elem Res, 2014, 159(1-3): 320-324. DOI: 10.1007/s12011-014-9971-1.
    [30]
    BAFFY G. Kupffer cells in non-alcoholic fatty liver disease: the emerging view[J]. J Hepatol, 2009, 51(1): 212-223. DOI: 10.1016/j.jhep.2009.03.008.
    [31]
    WU L, AI YC. Research progress on pathogenesis and etiology of acute pancreatitis[J]. J Qiqihar Med Coll, 2019, 40(5): 618-620. DOI: 10.3969/j.issn.1002-1256.2019.05.038.

    武亮, 艾迎春. 急性胰腺炎相关发病机制及病因的研究进展[J]. 齐齐哈尔医学院学报, 2019, 40(5): 618-620. DOI: 10.3969/j.issn.1002-1256.2019.05.038.
    [32]
    WU D, SONG LL, ZHAO YH. Study on the relationship between fatty liver and the grade of acute pancreatitis[J]. Chin J Lab Diag, 2018, 22(9): 1557-1559. DOI: 10.3969/j.issn.1007-4287.2018.09.023.

    吴迪, 宋玲玲, 赵艳辉. 脂肪肝与急性胰腺炎分级的关系研究[J]. 中国实验诊断学, 2018, 22(9): 1557-1559. DOI: 10.3969/j.issn.1007-4287.2018.09.023.
    [33]
    SONG Y, ZHANG P, XU SW, et al. Predictive value of CT evaluation of fatty liver for the severity of acute pancreatitis[J]. Chin J Postgrad Med, 2018, 41(8): 701-705. DOI: 10.3760/cma.j.issn.1673-4904.2018.08.008.

    宋宇, 张鹏, 许尚文, 等. CT评估脂肪肝对急性胰腺炎严重程度的预测价值[J]. 中国医师进修杂志, 2018, 41(8): 701-705. DOI: 10.3760/cma.j.issn.1673-4904.2018.08.008.
    [34]
    FREY C, ZHOU H, HARVEY D, et al. Co-morbidity is a strong predictor of early death and multi-organ system failure among patients with acute pancreatitis[J]. J Gastrointest Surg, 2007, 11(6): 733-742. DOI: 10.1007/s11605-007-0164-5.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Tables(5)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (752) PDF downloads(46) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return